---
figid: PMC3201097__bcbcr-5-2011-209f1
figtitle: The hormone signaling pathway and its inhibition as therapy in breast cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3201097
filename: bcbcr-5-2011-209f1.jpg
figlink: /pmc/articles/PMC3201097/figure/f1-bcbcr-5-2011-209/
number: F1
caption: 'The hormone signaling pathway and its inhibition as therapy in breast cancer.
  A) Estrogen receptor signaling. B) Receptor signaling inhibited by the selective
  estrogen receptor modulator tamoxifen and C) by aromatase inhibition.Abbreviations:
  A, androstenedione; AF, activating function; AND-5, androstenediol-5; AND-5S, androstenediol-5
  sulfate; DHEA, dehydroepiandrosterone; DHEA-S, dehydroepiandrosterone sulfate; E,
  estrogen; E1, estrone; E2, estradiol; ER, estrogen receptor; ERE, estrogen response
  element; RNA Pol II, ribonucleic acid polymerase II; T, tamoxifen. Panels A and
  B reprinted with permission from Johnston SR 2005. Panel C adapted with permission
  from Labrie F, Luu-The V, Lin SX, et al. J Mol Endocrinol 25:1–16 © Society for
  Endocrinology (2000).'
papertitle: Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal
  Women.
reftext: Muaiad Kittaneh, et al. Breast Cancer (Auckl). 2011;5:209-226.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8975703
figid_alias: PMC3201097__F1
figtype: Figure
redirect_from: /figures/PMC3201097__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3201097__bcbcr-5-2011-209f1.html
  '@type': Dataset
  description: 'The hormone signaling pathway and its inhibition as therapy in breast
    cancer. A) Estrogen receptor signaling. B) Receptor signaling inhibited by the
    selective estrogen receptor modulator tamoxifen and C) by aromatase inhibition.Abbreviations:
    A, androstenedione; AF, activating function; AND-5, androstenediol-5; AND-5S,
    androstenediol-5 sulfate; DHEA, dehydroepiandrosterone; DHEA-S, dehydroepiandrosterone
    sulfate; E, estrogen; E1, estrone; E2, estradiol; ER, estrogen receptor; ERE,
    estrogen response element; RNA Pol II, ribonucleic acid polymerase II; T, tamoxifen.
    Panels A and B reprinted with permission from Johnston SR 2005. Panel C adapted
    with permission from Labrie F, Luu-The V, Lin SX, et al. J Mol Endocrinol 25:1–16
    © Society for Endocrinology (2000).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Polr2A
  - Polr2C
  - Polr2B
  - Polr2I
  - Polr2F
  - Prim1
  - PolA1
  - PolA2
  - sv
  - Prim2
  - svr
  - lncRNA:noe
  - EFNA5
  - IFNGR2
  - PSMD4
  - ERVW-4
  - ELF3
  - SULT2A1
  - CYP19A1
  - Androstenedione
  - DHEA
  - estrogen
  - Testosterone
---
